about
Pay-for-Performance Contracts in Diabetes CareEfficacy and safety of saxagliptin as add-on therapy in type 2 diabetes.Innovations in Interdisciplinary Diabetes Management: When Better Isn't Good Enough.Impact of sociodemographic and diabetes-related factors on the presence and severity of depression in immigrant chinese Australian people with diabetesDiabetes numeracy and blood glucose control: association with type of diabetes and source of care.A framework for physician-dentist collaboration in diabetes and periodontitisDisparities in postpartum follow-up in women with gestational diabetes mellitus.Prevalence and determinants of anemia in older people with diabetes attending an outpatient clinic: a cross-sectional auditGestational diabetes mellitus screening using the one-step versus two-step method in a high-risk practice.Your Diabetes Care Provider in the Future Is Probably an NP or PA!Health Care Disparities and Diabetes Care: Practical Considerations for Primary Care ProvidersRare presentations of ketoacidosis: diabetic ketoalkalosis and ketoacidosis secondary to fasting and muscular dystrophy.Evaluating the effect of u-500 insulin therapy on glycemic control in veterans with type 2 diabetes.The diabetes attitudes, wishes and needs second study.Continuing medical education for promoting shared medical visits in diabetes careStandards of medical care in diabetes-2015 abridged for primary care providers.Pill Burden in Patients With Type 2 Diabetes in Germany: Subanalysis From the Prospective, Noninterventional PROVIL StudyAn Insurer-Based Diabetes Educator-Community Partnership: Leveraging Education and Diabetes Support (LEADS).Disparities in social support systems for youths with type 1 diabetes.Metformin With Either Histamine H2-Receptor Antagonists or Proton Pump Inhibitors: A Polypharmacy Recipe for Neuropathy via Vitamin B12 Depletion.Does your patient need diabetic therapeutic footwear? (Where benefit, evidence, and bureaucracy collide).Hemichorea-hemiballism as the first presentation of type 2 diabetesClinical Considerations for Insulin Pharmacotherapy in Ambulatory Care, Part One: Introduction and Review of Current Products and Guidelines.Speaking to Patients About Diabetes Risk: Is Terminology Important?Efficacy and Safety of Canagliflozin as Add-On Therapy to Metformin in Type 2 DiabetesObesity and Testosterone Levels in Ghanaian Men With Type 2 Diabetes.Results of the Epidemiology of Diabetes Interventions and Complications TrialAdherence to Guidelines for Hepatitis B, Pneumococcal, and Influenza Vaccination in Patients With Diabetes.Screening for Gestational Diabetes Mellitus: Are Guidelines From High-Income Settings Applicable to Poorer Countries?Insulin Therapy: A Personal ApproachDiabetes Has Gotten Pretty Darn Complicated.Dynamics, Impact, and Feasibility of Self-Monitoring of Blood Glucose in the Rural, Resource-Constrained Setting of Western KenyaSupraventricular Tachycardia With Underlying Atrial Flutter in a Diabetic Ketoacidosis Patient.SGLT-2 Inhibitors: A New Mechanism for Glycemic Control.Workplace Checkup: Keeping Patients With Diabetes Employed and Safe on the JobImpact of Performance-Improvement Strategies on the Clinical Care and Outcomes of Patients With Type 2 Diabetes.Older Adults' Perceived Challenges With Health Care Providers Treating Their Type 2 Diabetes and Comorbid Conditions.Optimizing the Care of Patients With Type 2 Diabetes Using Incretin-Based Therapy: Focus on GLP-1 Receptor Agonists.Continuing Educational Inertia?An Evaluation of the Current Type 2 Diabetes Guidelines: Where They Converge and Diverge
P1433
Q29027377-88D3D104-A45D-4CFA-8964-62E762EF338BQ34454269-5649B1BA-DFA0-4734-8C89-FE3E225C032CQ34454275-250BBEF1-A5EE-4D01-902F-3E91C2DCB22BQ34454280-01F883B8-79FA-4288-A5CD-77BCAC40336CQ34454285-098D0F3F-6BCE-4D9E-9DBD-EB1FD516958CQ34454291-85EB8F44-4910-4E17-A722-F4A3150A41ABQ34454297-FFA2B5BE-0C9A-4207-B111-5E2B55A2580BQ34454304-FB0781CD-1A66-4738-AF09-B99EE42D80B7Q34454313-50237F90-0A97-4AD5-8292-E841FB2047A2Q34454335-C3271CC5-FA92-4D6B-93E2-8CA63E2CAAE4Q34540562-F7FD6798-5900-4058-B439-3B2A9BB962E2Q34987582-F23FF675-FFBA-442B-9667-088B71A80ADCQ34987587-2B98C87E-4997-4C34-9528-3404E5CBB32EQ34987592-759DEBE8-57B5-4138-9BE0-C1E555D10F96Q34987597-5493BC4B-397F-43D3-A71A-F92F0E1C0FEBQ35428940-18E7D5B5-3471-44A1-A4A4-B0D0A94E762EQ35428960-9F96D650-A400-4035-ABF5-7A6099D43595Q35428980-A8A41C97-386D-42F6-9868-12E0702F26EBQ35429000-E95664DD-5369-484D-9CF2-6EBF4CF4EB35Q35429018-B13537FD-D9B7-4430-BB5A-EB2FDDB71AE6Q35429036-7DCEF786-C7E4-4C6A-9938-D85CA22EFE5CQ35429056-5AA562E4-90C3-4411-8280-41C869259B30Q35796626-ECDAC054-D608-49E2-9568-173DF3C5B7BDQ35796632-F76AD88A-BCA7-415D-9176-26F863D3D3A1Q35796638-8A6692B8-4BA7-48E9-BB73-16B375703E7FQ35796644-7CFC93D9-45D8-43D7-B6D2-8B3B9DF7DB57Q35856342-E9E8227E-5F84-4D4F-A863-17FC7B50A23CQ35856348-BA4342A6-783E-4E67-9347-BF4228C9DD65Q35856352-13835912-1210-4853-BD48-9E940FAA7F5FQ35856357-8722D379-6F34-4AF8-BA7F-85D20F97B2BAQ35856362-F03BFF96-7DDE-4039-B95E-6C78294465EBQ35856366-7B76CE57-1592-4163-B5E9-18F90857DCBAQ35856370-12C30A27-550E-41E5-93AE-7F97A6738CE0Q35906490-69009240-B2C8-4D38-9070-265883CF327BQ35906495-A8D6F90E-02B5-476E-ABF9-2C7A0A67D5E5Q35906500-839D888D-2BDD-4586-8F44-2B8C429A6613Q35906503-48A80B40-C1B4-4782-8A15-77E191087BD2Q35906506-334BCEEF-4907-4D95-BBBB-D81BD518B9FBQ35906511-5C68FF58-A0DC-4F83-863B-01308E04D04FQ35906516-436B1024-0DD2-44F6-B1AB-3D6A1CADB193
P1433
description
czasopismo naukowe
@pl
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift
@nl
wissenschaftliche Fachzeitschrift
@de
مجلة
@ar
name
Clinical Diabetes
@ast
Clinical Diabetes
@en
Clinical Diabetes
@es
Clinical Diabetes
@it
Clinical Diabetes
@nl
type
label
Clinical Diabetes
@ast
Clinical Diabetes
@en
Clinical Diabetes
@es
Clinical Diabetes
@it
Clinical Diabetes
@nl
prefLabel
Clinical Diabetes
@ast
Clinical Diabetes
@en
Clinical Diabetes
@es
Clinical Diabetes
@it
Clinical Diabetes
@nl
P31
P3181
P1055
P1056
P1058
P1156
P1476
Clinical Diabetes
@en